SCHEMBL14822360

SCHEMBL14822360

COCOCc1cn(CC2(COS(=O)(=O)c3ccc(C)cc3)COC(C)(C)OC2)c([N+](=O)[O-])n1

nearest known ligand 0.32

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 1/20 0.32
▸ NPC1 O15118 1/20 0.32
▸ LMNA P02545 1/20 0.32
▸ MAPT P10636 1/20 0.32
▸ NFKB1 P19838 1/20 0.32
▸ CASP3 P42574 1/20 0.32
▸ RAB9A P51151 1/20 0.32
▸ NFKB2 Q00653 1/20 0.32
▸ KMT2A Q03164 1/20 0.32
▸ RELA Q04206 1/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.32
▸ SENP8 Q96LD8 1/20 0.32
▸ SENP7 Q9BQF6 1/20 0.32
▸ SENP6 Q9GZR1 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15899135 0.85 — —
SCHEMBL15899192 0.82 MITF (0.31) —
SCHEMBL14822353 0.78 CA12 (0.39) LMNARAB9AKMT2A
SCHEMBL15899177 0.78 SMYD2 (0.32) —
SCHEMBL15899140 0.73 CA12 (0.41) LMNARAB9AKMT2A
SCHEMBL10047554 0.72 STAT3 (0.37) LMNAKMT2ASMN1; SMN2
SCHEMBL18589129 0.70 CA12 (0.38) LMNAMAPTRAB9AKMT2ASMN1; SMN2
SCHEMBL10015860 0.69 ALDH1A1 (0.37) LMNAKMT2ASMN1; SMN2
SCHEMBL18633388 0.68 CA12 (0.39) LMNAMAPTKMT2A
SCHEMBL15899193 0.67 MITF (0.32) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2759538-B1 RADIOACTIVE FLUORINE LABELED COMPOUND NIHON MEDIPHYSICS CO LTD (JP) 2016-03-23 — — EP disclosed
EP-2759538-B1 RADIOACTIVE FLUORINE LABELED COMPOUND NIHON MEDIPHYSICS CO LTD (JP) 2016-03-23 — — EP disclosed
US-9107964-B2 Radioactive fluorine-labeled compound NIHON MEDI-PHYSICS CO., LTD. (JP) 2015-08-18 — — US disclosed
US-9107964-B2 Radioactive fluorine-labeled compound NIHON MEDI-PHYSICS CO., LTD. (JP) 2015-08-18 — — US disclosed
US-20140364620-A1 RADIOACTIVE FLUORINE-LABELED COMPOUND NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY (JP) 2014-12-11 — — US disclosed
US-20140364620-A1 RADIOACTIVE FLUORINE-LABELED COMPOUND NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY (JP) 2014-12-11 — — US disclosed
EP-2759538-A1 RADIOACTIVE FLUORINE LABELED COMPOUND Nihon Medi-Physics Co., Ltd. (JP) 2014-07-30 — — EP disclosed
EP-2759538-A1 RADIOACTIVE FLUORINE LABELED COMPOUND Nihon Medi-Physics Co., Ltd. (JP) 2014-07-30 — — EP disclosed
WO-2013042668-A1 RADIOACTIVE FLUORINE LABELED COMPOUND 日本メジフィジックス株式会社 (JP) 2013-03-28 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140364620-A1 RADIOACTIVE FLUORINE-LABELED COMPOUND AFF1, PRMT1, DOT1L MEN1 14/4885NPC1 43/4885LMNA 4127/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback